Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O S Tang

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Contraception|January 5, 2002
Pilot study on the use of sublingual misoprostol for medical abortionO S Tang, P C Ho
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 27, 2007
Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancyA Faúndes, C Fiala, O S Tang, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 30, 2007
Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effectsO S Tang, K Gemzell-Danielsson, P C Ho
Human Reproduction (Oxford, England)|March 30, 2001
Measurement of serum CA-125 concentrations does not improve the value of Chlamydia trachomatis antibody in predicting tubal pathology at laparoscopyE H Ng, O S Tang, P C Ho
Contraception|September 6, 2001
Second trimester medical abortion with mifepristone and gemeprost: a review of 956 casesO S Tang, K J Thong, D T Baird
Human Reproduction (Oxford, England)|September 1, 2000
The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programmeE H Ng, O S Tang, P C Ho
Human Reproduction (Oxford, England)|September 28, 2000
Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancyS W Ngai, O S Tang, P C Ho
Contraception|January 4, 2001
Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort studyO S Tang, G Tang, P S Yip, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 1, 2004
A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of laborH Lam, O S Tang, C P Lee, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 27, 2007
Cervical priming with misoprostol prior to transcervical proceduresC Fiala, K Gemzell-Danielsson, O S Tang, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Contraception|January 5, 2002
Pilot study on the use of sublingual misoprostol for medical abortionO S Tang, P C Ho
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 27, 2007
Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancyA Faúndes, C Fiala, O S Tang, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 30, 2007
Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effectsO S Tang, K Gemzell-Danielsson, P C Ho
Human Reproduction (Oxford, England)|March 30, 2001
Measurement of serum CA-125 concentrations does not improve the value of Chlamydia trachomatis antibody in predicting tubal pathology at laparoscopyE H Ng, O S Tang, P C Ho
Contraception|September 6, 2001
Second trimester medical abortion with mifepristone and gemeprost: a review of 956 casesO S Tang, K J Thong, D T Baird
Human Reproduction (Oxford, England)|September 1, 2000
The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programmeE H Ng, O S Tang, P C Ho
Human Reproduction (Oxford, England)|September 28, 2000
Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancyS W Ngai, O S Tang, P C Ho
Contraception|January 4, 2001
Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort studyO S Tang, G Tang, P S Yip, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 1, 2004
A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of laborH Lam, O S Tang, C P Lee, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 27, 2007
Cervical priming with misoprostol prior to transcervical proceduresC Fiala, K Gemzell-Danielsson, O S Tang, et al.
Pageof 4